EBOS Group Limited
EBOSY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.01B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.01 Billion |
|---|---|
| Enterprise Value | $2.67 Billion |
| Annual dividend | $1.41 |
| Dividend yield | 5.86% |
| Earnings per Share | $4.3 |
| Beta | 0.16 |
| Outstanding Shares | 51,532,324 |
Return
| Return on Equity | 16.15% |
|---|---|
| Return on Assets | 5.67% |
| Return on Invested Capital | 15.95% |
Valuation & Multiples
| P/E Ratio | 15.62 |
|---|---|
| PEG | 9176.7 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.38 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | 3.4 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.71 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ebos Group Limited
6,200 employees
CEO: Adam Luke Hall
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segme...